鼻咽纤维血管瘤术前超选择性血管栓塞的应用价值

doi:10.6040/j.issn.1673-3770.1.2019.013

摘要/Abstract

摘要： 目的

分析鼻咽纤维血管瘤的临床特征、诊断方法、手术方式、预后以及术前行超选择性血管栓塞的临床应用价值。

方法

回顾性分析南京医科大学第一附属医院2007年1月~2018年7月收治的31例经病理证实为鼻咽部纤维血管瘤患者的临床资料。患者均依据术前影像学检查结果进行临床分期并制定手术方案（根据Radkowski分期，Ⅰa期患者11例、Ⅰb期7例、Ⅱa期7例、Ⅱb期3例、Ⅱc期2例、Ⅲa期 1例）。其中16例行经鼻内镜手术，9例行经硬腭径路，5例行经口腔径路,1例行鼻侧切开；13例患者术前行超选择性血管介入栓塞术。

结果

术后3例患者失访，其余28例患者平均随访6个月~5年，有5例患者出现复发。术前行超选择性动脉栓塞的患者手术时间和术中出血量较未栓塞患者均显著减少，差异具有统计学意义(P<0.05)。分期较晚的Ⅱ～Ⅲ期患者术前栓塞比例、术中出血量均明显高于Ⅰ期，差异具有统计学意义(P<0.05)。

结论

鼻咽纤维血管瘤临床表现多变，术前应通过详细的影像学检查手段如CT、MRI及数字血管造影检查等来进行准确的分期，Radkowski分期系统有助于指导该疾病的诊疗。术前行超选择性血管栓塞可显著减少术中出血、缩短手术时间并降低复发率。

关键词: 鼻咽纤维血管瘤, 肿瘤分期, 栓塞,治疗性, 外科手术, 预后

Abstract: Objective

To summarize and analyze the clinical features, diagnostic methods, surgical approach, prognosis, and clinical value of preoperative hyperselective vascular embolization for juvenile nasopharyngeal angiofibroma (JNA).

Methods

Retrospective analysis of 31 patients with pathologically confirmed nasopharyngeal fibroangioma in the First Affiliated Hospital of Nanjing Medical University from January 2007 to July 2018 was performed. All patients underwent clinical staging based on preoperative imaging findings (according to Radkowski staging, 11 cases in stage Ia, seven in Ib, seven in IIa, three in IIb, two in IIc, and one in IIIa) after which surgical plans were developed. Sixteen patients underwent nasopharyngeal angiofibroma resection via a nasal endoscopy approach, nine via a nasal-hard palate approach, five via an oral approach, and one via a nasal side incision approach. Among all patients, 13 patients underwent selective vascular interventional embolization before surgery.

Results

Three patients were lost to follow-up. The remaining 28 patients were followed up for 6 months to 5 years and five patients developed recurrence of the disease. The operation time and intraoperative blood loss of patients with hyperselective arterial embolization before surgery were significantly lower than those without embolization (P<0.05). Preoperative embolization rate and intraoperative blood loss were significantly higher in patients with stage II?III JNA (P<0.05).

Conclusion

The clinical manifestations of JNA are variable. Preoperative detailed imaging methods such as computed tomography, magnetic resonance imaging, and digital angiography can help to perform accurate staging and develop a reasonable surgical plan. Preoperative Radkowski staging helps to guide the treatment of JNA. Preoperative hyperselective vascular embolization can reduce intraoperative blood loss, reduce the operation time, and reduce the recurrence rate significantly, which is worth advocating further.

Key words: Juvenile nasopharyngeal angiofibroma, Neoplasm staging, Embolization， therapeutic, Surgical procedures, operative, Prognosis

中图分类号:

R765

赵青,周涵,殷敏,冯剑,张佳程,刘雅琴,沈宇杰,林子萍,董伟达. 鼻咽纤维血管瘤术前超选择性血管栓塞的应用价值[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 100-105.

Qing ZHAO,Han ZHOU,Min YIN,Jian FENG,Jiacheng ZHANG,Yaqin LIU,Yujie SHEN,Ziping LIN,Weida DONG. Value of preoperative hyperselective vascular embolization in juvenile nasopharyngeal angiofibroma treatment[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(3): 100-105.

图/表 4

表1

表2

图1

图2

参考文献 15

1	魏玉梅, 蔡晓岚, 张国丽, 等. 鼻咽纤维血管瘤研究进展[J]. 山东大学耳鼻喉眼学报, 2006, 20(3): 193-196. doi:10.3969/j.issn.1673-3770.2006.03.001. doi: 10.3969/j.issn.1673-3770.2006.03.001
2	PeiR, YangM, WangJ,et al.Efficacy and safety of preoperative internal maxillary arterial embolization with gelfoam for nasopharyngeal angiofibroma[J]. Eur Arch Otorhinolaryngol,2019, Jan 3.doi:10.1007/s00405-018-05276-6 doi: 10.1007/s00405-018-05276-6
3	刘婷婷, 王学海, 蔡晓岚, 等. 鼻内镜下口-鼻联合径路切除鼻底累及硬腭巨大肿瘤两例[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 108-111. doi:10.6040/j.issn.1673-3770.0.2017.333. doi: 10.6040/j.issn.1673-3770.0.2017.333
	LIUTingting, WANGXuehai, CAIXiaolan, et al. Excision of giant tumor in nasal floor involving palatine via oral-nasal combined approach under a nasal endoscope assisted: a report of 2 cases[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(3): 108-111. doi:10.6040/j.issn.1673-3770.0.2017.333. doi: 10.6040/j.issn.1673-3770.0.2017.333
4	秦贺, 胡斌, 叶京英, 等. 鼻和咽部原发性非霍奇金淋巴瘤17例临床分析[J]. 山东大学耳鼻喉眼学报, 2017, 31(4): 51-53. doi:10.6040/j.issn.1673-3770.0.2017.199. doi: 10.6040/j.issn.1673-3770.0.2017.199
	QINHe, HUBin, YEJingying, et al. Clinical analysis of 17 patients with primary non-Hodgkin's lymphoma in the nose and the pharynx[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2017, 31(4): 51-53. doi:10.6040/j.issn.1673-3770.0.2017.199. doi: 10.6040/j.issn.1673-3770.0.2017.199
5	LópezF, TriantafyllouA, SnydermanCH, et al. Nasal juvenile angiofibroma: Current perspectives with emphasis on management[J]. Head Neck, 2017, 39(5): 1033-1045. doi:10.1002/hed.24696. doi: 10.1002/hed.24696
6	JanakiramN, SharmaSB, PanickerVB,etal. A drastic aftermath of embolisation in juvenile nasopharyngeal angiofibroma[J]. Indian J Otolaryngol Head Neck Surg ,2016,68:540-543.doi:10.1007/s12070-016-1014-0 doi: 10.1007/s12070-016-1014-0
7	吴贤敏, 李志春, 易自翔, 等. 鼻咽血管纤维瘤的研究现状[J]. 山东大学耳鼻喉眼学报, 2007, 21(1): 81-85. doi:10.3969/j.issn.1673-3770.2007.01.027. doi: 10.3969/j.issn.1673-3770.2007.01.027
8	Oré AcevedoJF, La Torre CaballeroLM, Urteaga QuirogaRJ. Juvenile nasopharyngeal angiofibroma surgical treatment in paediatric patients[J]. Acta Otorrinolaringol Esp, 2018: S0001-S6519(18)30125-0. doi:10.1016/j.otorri.2018.06.003. doi: 10.1016/j.otorri.2018.06.003
9	蔡葶, 周兵, 黄谦, 等. 鼻内镜下鼻咽纤维血管瘤切除术预后因素分析[J]. 临床耳鼻咽喉头颈外科杂志, 2010, 24(22): 1035-1039. doi:10.3969/j.issn.1001-1781.2010.22.009. doi: 10.3969/j.issn.1001-1781.2010.22.009
	CAITing, ZHOUBing, HUANGQian, et al. Analysis of prognostic factors in endoscopic surgery for juvenile nasopharyngeal angiofibroma[J]. Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 2010, 24(22): 1035-1039. doi:10.3969/j.issn.1001-1781.2010.22.009. doi: 10.3969/j.issn.1001-1781.2010.22.009
10	孙景元. 内窥镜下超声刀切除鼻咽纤维血管瘤的临床效果分析[J]. 临床医药文献电子杂志, 2017, 4(49): 9545. doi:10.3877/j.issn.2095-8242.2017.49.027. doi: 10.3877/j.issn.2095-8242.2017.49.027
11	YiZX, FangZM, LinGB, et al. Nasopharyngeal angiofibroma: a concise classification system and appropriate treatment options[J]. Am J Otolaryngol, 2013, 34(2): 133-141. doi:10.1016/j.amjoto.2012.10.004. doi: 10.1016/j.amjoto.2012.10.004
12	MehanR, RupaV, LukkaVK, et al. Association between vascular supply, stage and tumour size of juvenile nasopharyngeal angiofibroma[J]. Eur Arch Otorhinolaryngol, 2016, 273(12): 4295-4303. doi:10.1007/s00405-016-4136-9. doi: 10.1007/s00405-016-4136-9
13	TrivediM., DesaiRJ, Potdar NA, et al. Vision loss due to central retinal artery occlusion following embolization in a case of a giant juvenile nasopharyngeal angiofibroma[J]. Journal of Craniofacial Surgery, 2015, 26(5): 451-453.doi:10.1097/scs.0000000000-001936 doi: 10.1097/scs.0000000000-001936
14	GarofaloP, PiaF, PolicarpoM, et al. Juvenile nasopharyngeal angiofibroma: comparison between endoscopic and open operative approaches[J]. J Craniofac Surg, 2015, 26(3): 918-821. doi:10.1097/SCS.00000000000-01693. doi: 10.1097/SCS.00000000000-01693
15	TanG, MaZ, LongW, et al. Efficacy of preoperative transcatheter arterial embolization for nasopharyngeal angiofibroma: a comparative study[J]. Cardiovasc Interv Radiol,2017, 40（6）:836-844. doi： 10.1007/s00270-017-1587-3. doi: 10.1007/s00270-017-1587-3

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed

指标	术前栓塞组	对照组	P	Wilcoxon W
肿瘤最大径（cm）	3.2±1.3	3.0±1.3	0.600	275.000
术中出血量（mＬ）	432.3±157.8	763.9±282.7	0.001	124.500
住院总天数（d）	11.0±5.4	11.9±4.9	0.376	186.000
术后住院天数（d）	5.8±3.3	6.7±4.0	0.404	187.500
手术时间（min）	72.7±23.0	112.8±45.4	0.035	155.500
复发[n(%)]	1（7.7）	4（22.2）	0.368^＃	/

指标	早期（Ⅰ期）	中晚期（Ⅱ,Ⅲ期）	Wilcoxon W	P
术前栓塞[n (%)]	4/18（22.2）	9/13（69.2）	/	0.013^#
肿瘤最大径(cm)	2.2±0.7	4.3±0.8	177.500	＜0.001
手术时间(min)	100.2±49.6	95.6±31.5	202.500	0.825
术中出血量（mL）	507.2±195.7	787.7±321.8	227.500	0.015
总住院天数（d）	12.2±6.0	10.6±3.5	195.000	0.601
术后住院天数（d）	6.9±4.0	5.5±3.1	172.500	0.148
复发[n（%）]	1（4.0）	4（30.8）	/	0.134^#

[1]	李晓明. 喉癌治疗中喉功能保留的历史、现状和未来[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 1-5.
[2]	孙笑晗,李娜. 喉保留策略在喉癌治疗中的应用——美国临床肿瘤学会临床实践指南更新(2017)介绍[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 40-42.
[3]	丁洁,孙彦. 142例喉癌术后患者整体睡眠质量状况调查分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 76-81.
[4]	黄河,欧阳晖. 下咽癌共病食管癌的高危因素及预后分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 82-86.
[5]	汤苏成,王跃建,陈伟雄. 颈源性纵隔脓肿手术切开概率增加的危险因素分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 87-91.
[6]	陈慧君,宋圣花,周涵,董伟达,乔明哲,陈曦,徐进,林子萍,邢光前. 血小板与淋巴细胞比值对喉癌复发的预测价值[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 106-110.
[7]	沈宇杰,张立庆,周涵,赵青,冯剑,宋圣花,董伟达. 颈部脂肪瘤34例临床分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 111-115.
[8]	张佳程,张立庆,周涵,陆美萍,许万云,沈宇杰,刘雅琴,殷敏,董伟达. 鼻腔鼻窦恶性黑色素瘤23例临床分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 95-99.
[9]	王登元, 陈智斌, 邢光前. 耳内镜微创术——耳科手术的新途径[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 27-30.
[10]	姜彦. 鼻咽癌复发及鼻内镜外科手术的应用[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 1-11.
[11]	陈冬平,杨致欢,张炎,方楠,齐斌. 复发鼻咽癌手术治疗地位的思考[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 12-16.
[12]	邱前辉,陈卓. 鼻内镜手术治疗首诊局部晚期鼻咽癌及放疗后严重并发症的作用[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 17-20.
[13]	陆海军,刘霁,丁晓. 鼻咽癌的综合治疗研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 26-30.
[14]	徐文瑞,姜彦. 复发鼻咽癌挽救性手术方法研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 35-38.
[15]	刘全,孙希才,于华鹏,赵可庆,张焕康,赵卫东,顾瑜蓉,李厚勇,王德辉,余洪猛. 鼻内镜下鼻咽癌切除术的手术分型[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 39-45.